A novel nanobody as therapeutics target for EGFR-positive colorectal cancer therapy: exploring the effects of the nanobody on SW480 cells using proteomics approach
Thomanai Lamtha(Nation University), Kiattawee Choowongkomon(Kasetsart University), Pawitrabhorn Samutrtai(Chiang Mai University), Lueacha Tabtimmai(King Mongkut's University of Technology North Bangkok), Sucheewin Krobthong(Kasetsart University), Yodying Yingchutrakul(National Science and Technology Development Agency), Christopher Gerner(University of Vienna)
Cited by 11
Related Papers
Inhaled Nanoparticles Accumulate at Sites of Vascular Disease
|ACS Nano|2017|617
Proteome analysis of nuclear matrix proteins during apoptotic chromatin condensation
|Cell Death and Differentiation|2002|68
Human intestinal bitter taste receptors regulate innate immune responses and metabolic regulators in obesity
|DOAJ (DOAJ: Directory of Open Access Journals)|2022|48
Seasonal variation in UVA light drives hormonal and behavioural changes in a marine annelid via a ciliary opsin
|Nature Ecology & Evolution|2021|46